Literature DB >> 9531282

Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation.

L A Zuckerman1, L Pullen, J Miller.   

Abstract

LFA-1 is a well-recognized adhesion molecule, but its role in providing costimulatory signals to T cells has remained controversial. We have compared the ability of class II-positive transfectants that do and do not coexpress ICAM-1 (ProAd and ProAd-ICAM) to activate Ag-specific Th1 clones and naive CD4-positive T cells isolated from TCR transgenic mice. Ag presentation by ProAd to Th1 clones can induce calcium-dependent signaling events after engagement of the TCR, as evidenced by the nuclear localization of the transcription factors NF-AT and NF-kappaB. Nevertheless, coexpression of ICAM-1 or B7-1 on ProAd is required to induce detectable levels of IL-2 gene expression in either Th1 clones or naive T cells. In Th1 clones, activation by ProAd-ICAM induces very transient IL-2 mRNA expression that does not result in detectable IL-2 secretion or T cell proliferation. In naive T cells, the duration of IL-2 mRNA expression is longer, allowing for a transient burst of IL-2 protein that is sufficient to drive the cells into the cell cycle. In spite of this initial response, Ag presentation by ProAd-ICAM is a tolerogenic signal to naive T cells, and responding T cells undergo apoptosis 4 to 5 days poststimulation. These data suggest that engagement of LFA-1 can provide sufficient costimulatory signals to induce T cell activation and IL-2 gene expression, but cannot protect against anergy induction or provide for T cell survival.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531282

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Inhibition of tyrosine kinases blocks adhesion-induced T-cell coactivation without interfering with T-cell adhesion to endothelial cell-surface ligands.

Authors:  Dawn M Nowlin; Pina M Cardarelli; Lynn Young; Jason Mah; Katherine A Felts; Marian Mastrangelo; Ronald R Cobb
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

Review 2.  Diverse roles of integrins in human T lymphocyte biology.

Authors:  Yuko J Miyamoto; Bernard F Andruss; Jason S Mitchell; Matthew J Billard; Bradley W McIntyre
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients.

Authors:  Amena W Smith; Bently P Doonan; William R Tyor; Nada Abou-Fayssal; Azizul Haque; Naren L Banik
Journal:  J Neuroimmunol       Date:  2010-11-13       Impact factor: 3.478

4.  Cutting edge: A role for inside-out signaling in TCR regulation of CD28 ligand binding.

Authors:  Mariano Sanchez-Lockhart; Minsoo Kim; Jim Miller
Journal:  J Immunol       Date:  2011-11-07       Impact factor: 5.422

5.  LFA-1-mediated T cell costimulation through increased localization of TCR/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse.

Authors:  Beth Graf; Timothy Bushnell; Jim Miller
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

6.  Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.

Authors:  Jeremy I Pearl; Andrew S Lee; Dennis B Leveson-Gower; Ning Sun; Zhumur Ghosh; Feng Lan; Julia Ransohoff; Robert S Negrin; Mark M Davis; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

7.  Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors.

Authors:  Enxiu Wang; Liang-Chuan Wang; Ching-Yi Tsai; Vijay Bhoj; Zack Gershenson; Edmund Moon; Kheng Newick; Jing Sun; Albert Lo; Timothy Baradet; Michael D Feldman; David Barrett; Ellen Puré; Steven Albelda; Michael C Milone
Journal:  Cancer Immunol Res       Date:  2015-05-04       Impact factor: 11.151

8.  Naringin attenuates the development of carrageenan-induced acute lung inflammation through inhibition of NF-κb, STAT3 and pro-inflammatory mediators and enhancement of IκBα and anti-inflammatory cytokines.

Authors:  Sheikh Fayaz Ahmad; Sabry M Attia; Saleh A Bakheet; Khairy M A Zoheir; Mushtaq Ahmad Ansari; Hesham M Korashy; Hala E Abdel-Hamied; Abdelkader E Ashour; Adel R A Abd-Allah
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

9.  Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients.

Authors:  Jason M Zimmerer; Phillip H Horne; Lori A Fiessinger; Mason G Fisher; Kartika Jayashankar; Sierra F Garcia; Mahmoud Abdel-Rasoul; Nico van Rooijen; Ginny L Bumgardner
Journal:  Cell Transplant       Date:  2012-10-11       Impact factor: 4.064

Review 10.  Translating costimulation blockade to the clinic: lessons learned from three pathways.

Authors:  Mandy L Ford; Christian P Larsen
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.